Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael C Risk

Showing results (1-10 of 26) with videos related to

Pageof 3
Sort By:
Expert Review of Anticancer Therapy|June 17, 2014
Management of clinical stage I nonseminomatous germ cell tumorsSumit Isharwal, Michael C Risk
Indian Journal of Urology : IJU : Journal of the Urological Society of India|November 26, 2015
Diagnostics techniques in nonmuscle invasive bladder cancerAyman Soubra, Michael C Risk
Current Urology Reports|April 18, 2009
New and novel markers for prostate cancer detectionMichael C Risk, Daniel W Lin
Indian Journal of Urology : IJU : Journal of the Urological Society of India|June 11, 2010
Intratubular germ cell neoplasms of the testis and bilateral testicular tumors: clinical significance and management optionsMichael C Risk, Timothy A Masterson
Expert Review of Anticancer Therapy|December 21, 2010
Postchemotherapy retroperitoneal lymph node dissection for testis cancerMichael C Risk, Richard S Foster
World Journal of Urology|March 27, 2009
Management of non-germinal testicular tumorsMichael C Risk, Christopher R Porter
The Urologic Clinics of North America|April 14, 2018
Lymphadenectomy for Muscle-Invasive Bladder Cancer and Upper Tract Urothelial Cell CarcinomaNiranjan J Sathianathen, Michael C Risk, Badrinath R Konety
Seminars in Cancer Biology|February 16, 2013
PMN and anti-tumor immunity--the case of bladder cancer immunotherapyErik L Brincks, Michael C Risk, Thomas S Griffith
Cancers|July 15, 2026
Prostate Cancer Treatment: Cryoablation in ContextThomas Lilieholm, Michael C Risk, David Jarrard, et al.
The Journal of Urology|October 20, 2009
Effect of collecting duct histology on renal cell cancer outcomeJonathan L Wright, Michael C Risk, James Hotaling, et al.
Pageof 3

Showing results (1-10 of 26) with videos related to

Sort By:
Pageof 3
Expert Review of Anticancer Therapy|June 17, 2014
Management of clinical stage I nonseminomatous germ cell tumorsSumit Isharwal, Michael C Risk
Indian Journal of Urology : IJU : Journal of the Urological Society of India|November 26, 2015
Diagnostics techniques in nonmuscle invasive bladder cancerAyman Soubra, Michael C Risk
Current Urology Reports|April 18, 2009
New and novel markers for prostate cancer detectionMichael C Risk, Daniel W Lin
Indian Journal of Urology : IJU : Journal of the Urological Society of India|June 11, 2010
Intratubular germ cell neoplasms of the testis and bilateral testicular tumors: clinical significance and management optionsMichael C Risk, Timothy A Masterson
Expert Review of Anticancer Therapy|December 21, 2010
Postchemotherapy retroperitoneal lymph node dissection for testis cancerMichael C Risk, Richard S Foster
World Journal of Urology|March 27, 2009
Management of non-germinal testicular tumorsMichael C Risk, Christopher R Porter
The Urologic Clinics of North America|April 14, 2018
Lymphadenectomy for Muscle-Invasive Bladder Cancer and Upper Tract Urothelial Cell CarcinomaNiranjan J Sathianathen, Michael C Risk, Badrinath R Konety
Seminars in Cancer Biology|February 16, 2013
PMN and anti-tumor immunity--the case of bladder cancer immunotherapyErik L Brincks, Michael C Risk, Thomas S Griffith
Cancers|July 15, 2026
Prostate Cancer Treatment: Cryoablation in ContextThomas Lilieholm, Michael C Risk, David Jarrard, et al.
The Journal of Urology|October 20, 2009
Effect of collecting duct histology on renal cell cancer outcomeJonathan L Wright, Michael C Risk, James Hotaling, et al.
Pageof 3